- Home
- CRNX vs ESNT Comparison
CRNX vs ESNT Comparison
Compare CRNX & ESNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRNX
- ESNT
- Stock Information
- Founded
- CRNX 2008
- ESNT 2008
- Country
- CRNX United States
- ESNT Bermuda
- Employees
- CRNX N/A
- ESNT N/A
- Industry
- CRNX Biotechnology: Pharmaceutical Preparations
- ESNT Property-Casualty Insurers
- Sector
- CRNX Health Care
- ESNT Finance
- Exchange
- CRNX Nasdaq
- ESNT Nasdaq
- Market Cap
- CRNX 2.8B
- ESNT N/A
- IPO Year
- CRNX 2018
- ESNT 2013
- Fundamental
- Price
- CRNX $33.77
- ESNT $63.35
- Analyst Decision
- CRNX Strong Buy
- ESNT Buy
- Analyst Count
- CRNX 7
- ESNT 6
- Target Price
- CRNX $74.33
- ESNT $63.67
- AVG Volume (30 Days)
- CRNX 1.1M
- ESNT 454.6K
- Earning Date
- CRNX 11-11-2025
- ESNT 10-31-2025
- Dividend Yield
- CRNX N/A
- ESNT 1.96%
- EPS Growth
- CRNX N/A
- ESNT N/A
- EPS
- CRNX N/A
- ESNT 6.85
- Revenue
- CRNX $1,392,000.00
- ESNT $1,268,306,000.00
- Revenue This Year
- CRNX $489.51
- ESNT $4.27
- Revenue Next Year
- CRNX $661.93
- ESNT $1.47
- P/E Ratio
- CRNX N/A
- ESNT $9.25
- Revenue Growth
- CRNX 0.51
- ESNT 5.28
- 52 Week Low
- CRNX $24.10
- ESNT $51.61
- 52 Week High
- CRNX $62.53
- ESNT $65.34
- Technical
- Relative Strength Index (RSI)
- CRNX 56.44
- ESNT 57.42
- Support Level
- CRNX $33.19
- ESNT $62.70
- Resistance Level
- CRNX $37.23
- ESNT $64.42
- Average True Range (ATR)
- CRNX 1.45
- ESNT 0.92
- MACD
- CRNX 0.11
- ESNT -0.14
- Stochastic Oscillator
- CRNX 52.12
- ESNT 55.66
About CRNX Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.